|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 8 (October 15), 1999:
pp. 2637-2646
Genetic Modification of Human B-Cell Development: B-Cell
Development Is Inhibited by the Dominant Negative Helix Loop Helix
Factor Id3
Ana C. Jaleco,
Alexander P.A. Stegmann,
Mirjam H.M. Heemskerk,
Franka Couwenberg,
Arjen Q. Bakker,
Kees Weijer, and
Hergen Spits
From the Division of Immunology, The Netherlands Cancer Institute,
Antoni van Leeuwenhoek Huis, Amsterdam, The Netherlands.
Transgenic and gene targeted mice have contributed greatly to our
understanding of the mechanisms underlying B-cell development. We
describe here a model system that allows us to apply molecular genetic
techniques to the analysis of human B-cell development. We constructed
a retroviral vector with a multiple cloning site connected to a gene
encoding green fluorescent protein by an internal ribosomal entry site.
Human CD34+CD38 fetal liver cells,
cultured overnight in a combination of stem cell factor and
interleukin-7 (IL-7), could be transduced with 30% efficiency. We
ligated the gene encoding the dominant negative helix loop helix (HLH)
factor Id3 that inhibits many enhancing basic HLH transcription factors
into this vector. CD34+CD38 FL cells were
transduced with Id3-IRES-GFP and cultured with the murine stromal cell
line S17. In addition, we cultured the transduced cells in a
reaggregate culture system with an SV-transformed human fibroblast cell
line (SV19). It was observed that overexpression of Id3 inhibited
development of B cells in both culture systems. B-cell development was
arrested at a stage before expression of the IL-7R . The development
of CD34+CD38 cells into
CD14+ myeloid cells in the S17 system was not inhibited
by overexpression of Id3. Moreover, Id3+ cells, although
inhibited in their B-cell development, were still able to develop into
natural killer (NK) cells when cultured in a combination of Flt-3L,
IL-7, and IL-15. These findings confirm the essential role of bHLH
factors in B-cell development and demonstrate the feasibility of
retrovirus-mediated gene transfer as a tool to genetically modify human
B-cell development.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. U. van Lent, M. Nagasawa, M. M. van Loenen, R. Schotte, T. N. M. Schumacher, M. H. M. Heemskerk, H. Spits, and N. Legrand
Functional Human Antigen-Specific T Cells Produced In Vitro Using Retroviral T Cell Receptor Transfer into Hematopoietic Progenitors
J. Immunol.,
October 15, 2007;
179(8):
4959 - 4968.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Perry, Y. Zhao, L. Nie, S. W. Cochrane, Z. Huang, and X.-H. Sun
Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance
Blood,
October 1, 2007;
110(7):
2351 - 2360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Zhou, H. Chen, F. Lu, H. Sellak, J. A. Daigle, M. F. Alexeyev, Y. Xi, J. Ju, J. A. van Mourik, and S. Wu
Cav3.1 ({alpha}1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells
Am J Physiol Lung Cell Mol Physiol,
April 1, 2007;
292(4):
L833 - L844.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Touma, Z.-Y. J. Sun, L. K. Clayton, W. E. Marissen, A. M. Kruisbeek, G. Wagner, and E. L. Reinherz
Importance of the CD3{gamma} Ectodomain Terminal beta-Strand and Membrane Proximal Stalk in Thymic Development and Receptor Assembly
J. Immunol.,
March 15, 2007;
178(6):
3668 - 3679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Shimizu, L. Esaki, H. Mizuno, and K. Takeda
Granulocyte macrophage colony-stimulating factor enhances retinoic acid-induced gene expression
J. Leukoc. Biol.,
October 1, 2006;
80(4):
889 - 896.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Buitenhuis, H. W. M. van Deutekom, L. P. Verhagen, A. Castor, S. E. W. Jacobsen, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer
Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2
Blood,
June 1, 2005;
105(11):
4272 - 4281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Schotte, M. Nagasawa, K. Weijer, H. Spits, and B. Blom
The ETS Transcription Factor Spi-B Is Required for Human Plasmacytoid Dendritic Cell Development
J. Exp. Med.,
December 6, 2004;
200(11):
1503 - 1509.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Haan, P. Ferguson, U. Sommer, M. Hiremath, D. W. McVicar, P. C. Heinrich, J. A. Johnston, and N. A. Cacalano
Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation
J. Biol. Chem.,
August 22, 2003;
278(34):
31972 - 31979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Bovia, P. Salmon, T. Matthes, K. Kvell, T. H. Nguyen, C. Werner-Favre, M. Barnet, M. Nagy, F. Leuba, J.-F. Arrighi, et al.
Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors
Blood,
March 1, 2003;
101(5):
1727 - 1733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Schotte, M.-C. Rissoan, N. Bendriss-Vermare, J.-M. Bridon, T. Duhen, K. Weijer, F. Briere, and H. Spits
The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development
Blood,
February 1, 2003;
101(3):
1015 - 1023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. I. D. Rossi, T. Yokota, K. L. Medina, K. P. Garrett, P. C. Comp, A. H. Schipul Jr, and P. W. Kincade
B lymphopoiesis is active throughout human life, but there are developmental age-related changes
Blood,
January 15, 2003;
101(2):
576 - 584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Becker-Herman, F. Lantner, and I. Shachar
Id2 Negatively Regulates B Cell Differentiation in the Spleen
J. Immunol.,
June 1, 2002;
168(11):
5507 - 5513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Weijer, C. H. Uittenbogaart, A. Voordouw, F. Couwenberg, J. Seppen, B. Blom, F. A. Vyth-Dreese, and H. Spits
Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo
Blood,
April 15, 2002;
99(8):
2752 - 2759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Jaleco, H. Neves, E. Hooijberg, P. Gameiro, N. Clode, M. Haury, D. Henrique, and L. Parreira
Differential Effects of Notch Ligands Delta-1 and Jagged-1 in Human Lymphoid Differentiation
J. Exp. Med.,
October 1, 2001;
194(7):
991 - 1002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ruiz-Vela, F. Serrano, M. A. Gonzalez, J. L. Abad, A. Bernad, M. Maki, and C. Martinez-A
Transplanted Long-Term Cultured Pre-BI Cells Expressing Calpastatin Are Resistant to B Cell Receptor-induced Apoptosis
J. Exp. Med.,
July 30, 2001;
194(3):
247 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Beger, L. N. Pierce, M. Kruger, E. G. Marcusson, J. M. Robbins, P. Welcsh, P. J. Welch, K. Welte, M.-C. King, J. R. Barber, et al.
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach
PNAS,
January 2, 2001;
98(1):
130 - 135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Spits, F. Couwenberg, A. Q. Bakker, K. Weijer, and C. H. Uittenbogaart
Id2 and Id3 Inhibit Development of CD34+ Stem Cells into Predendritic Cell (Pre-DC)2 but Not into Pre-DC1: Evidence for a Lymphoid Origin of Pre-DC2
J. Exp. Med.,
December 18, 2000;
192(12):
1775 - 1784.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
